BDSI BioDelivery Sciences International, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

BDSI [NASD]

BioDelivery Sciences International, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.19	Insider Own	2.80%	Shs Outstand	95.81M	Perf Week	11.47%
Market Cap	363.12M	Forward P/E	6.68	EPS next Y	0.57	Insider Trans	-72.20%	Shs Float	93.24M	Perf Month	-24.65%
Income	-15.30M	PEG	-	EPS next Q	0.03	Inst Own	74.20%	Short Float	3.53%	Perf Quarter	-40.22%
Sales	111.40M	P/S	3.26	EPS this Y	74.90%	Inst Trans	11.72%	Short Ratio	2.74	Perf Half Y	-9.98%
Book/sh	0.79	P/B	4.80	EPS next Y	160.09%	ROA	-9.70%	Target Price	7.93	Perf Year	-26.83%
Cash/sh	0.67	P/C	5.68	EPS next 5Y	25.00%	ROE	-26.50%	52W Range	2.85 - 7.21	Perf YTD	-40.03%
Dividend	-	P/FCF	33.01	EPS past 5Y	30.30%	ROI	2.90%	52W High	-47.57%	Beta	0.68
Dividend %	-	Quick Ratio	2.00	Sales past 5Y	23.40%	Gross Margin	80.60%	52W Low	32.63%	ATR	0.36
Employees	178	Current Ratio	2.20	Sales Q/Q	75.60%	Oper. Margin	3.40%	RSI (14)	45.77	Volatility	7.14% 10.01%
Optionable	Yes	Debt/Eq	0.84	EPS Q/Q	92.00%	Profit Margin	-13.70%	Rel Volume	0.72	Prev Close	3.79
Shortable	Yes	LT Debt/Eq	0.84	Earnings	Mar 12 AMC	Payout	-	Avg Volume	1.20M	Price	3.78
Recom	1.60	SMA20	0.60%	SMA50	-19.46%	SMA200	-24.29%	Volume	415,331	Change	-0.26%

Jan-09-20

Initiated

Piper Sandler

Overweight

Mar-20-19

Initiated

SunTrust

Buy

Jan-31-19

Resumed

Janney

Buy

Jan-26-18

Initiated

Seaport Global Securities

Buy

Aug-14-17

Resumed

Cantor Fitzgerald

Overweight

$4.50

Aug-10-17

Reiterated

H.C. Wainwright

Buy

$4 → $5

May-26-17

Initiated

H.C. Wainwright

Buy

May-17-17

Upgrade

Cantor Fitzgerald

Neutral → Overweight

May-12-16

Reiterated

Piper Jaffray

Overweight

$6 → $4

May-11-16

Downgrade

Cantor Fitzgerald

Buy → Hold

May-04-16

Reiterated

FBR Capital

Outperform

$12 → $9

Mar-14-16

Reiterated

Laidlaw

Buy

$17 → $11

Mar-11-16

Reiterated

FBR Capital

Outperform

$13 → $12

Feb-08-16

Initiated

Piper Jaffray

Overweight

Nov-10-15

Reiterated

FBR Capital

Mkt Perform

$17 → $14

Nov-04-15

Initiated

Cantor Fitzgerald

Buy

May-12-15

Reiterated

Cantor Fitzgerald

Buy

$17 → $12

May-11-15

Reiterated

ROTH Capital

Buy

$16 → $14

Apr-22-15

Resumed

Piper Jaffray

Overweight

Apr-02-15

Initiated

FBR Capital

Outperform

$19

Mar-24-20 10:02PM	Edited Transcript of BDSI earnings conference call or presentation 12-Mar-20 8:30pm GMT Thomson Reuters StreetEvents +9.32%
Mar-14-20 08:51AM	Does BioDelivery Sciences International (NASDAQ:BDSI) Have A Healthy Balance Sheet? Simply Wall St.
Mar-13-20 09:29AM	BioDelivery (BDSI) Q4 Earnings and Revenues Beat Estimates Zacks +9.84%
Mar-12-20 08:55PM	BioDelivery Sciences International (BDSI) Tops Q4 Earnings and Revenue Estimates Zacks -5.05%
04:01PM	BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 Results GlobeNewswire
02:30PM	BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Mar-09-20 08:00AM	BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of Directors GlobeNewswire -6.05%
Mar-05-20 12:30PM	BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy? Zacks
Feb-27-20 05:15PM	BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicines 36th Annual Meeting GlobeNewswire
Feb-24-20 02:59PM	Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus American City Business Journals -5.58%
Feb-20-20 08:00AM	BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 GlobeNewswire
Feb-06-20 10:44AM	Emmaus (EMMA) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-30-20 10:15AM	Alexion (ALXN) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Jan-29-20 10:06AM	Gilead's Mantle Cell Lymphoma Drug MAA Gets EMA Validation Zacks
Jan-27-20 05:20PM	Here's Why You Should Add BioDelivery Stock to Your Portfolio Zacks
10:25AM	Will Soliris, Ultomiris Drive Alexion's (ALXN) Q4 Earnings? Zacks
Jan-13-20 08:30AM	BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Access for Symproic GlobeNewswire
Jan-08-20 12:00PM	What Makes BioDelivery (BDSI) a New Buy Stock Zacks
Jan-06-20 08:30AM	BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development GlobeNewswire
Dec-30-19 09:44AM	Flexion's (FLXN) Stock Up on FDA Approval for Zilretta sNDA Zacks
Dec-27-19 07:53PM	Argo Group, Tivity Health, Horizon Global, and Other 13D Filings Barrons.com -6.52%
Dec-25-19 12:00PM	Are You Looking for a Top Momentum Pick? Why BioDelivery Sciences International (BDSI) is a Great Choice Zacks
Dec-19-19 08:30AM	BioDelivery Sciences Added to NASDAQ Biotechnology Index GlobeNewswire
Dec-12-19 11:30AM	BioDelivery (BDSI) Up 6% Since Last Earnings Report: Can It Continue? Zacks
Dec-10-19 10:48AM	Did Hedge Funds Drop The Ball On BioDelivery Sciences International, Inc. (BDSI) ? Insider Monkey
Dec-06-19 12:00PM	What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Dec-05-19 09:07AM	Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon Zacks
Dec-04-19 11:05AM	Edited Transcript of BDSI earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
10:06AM	Zacks.com featured highlights include: Sciences International, Air Industries, Hallmark Financial Services and Vector Zacks
Dec-03-19 09:16AM	Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU Zacks
08:57AM	5 Affordable Breakout Stocks for Stunning Returns Zacks
Nov-29-19 09:13AM	BioDelivery's Belbuca Sales & Symproic Addition Encouraging Zacks
Nov-27-19 08:30AM	BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire +5.93%
Nov-25-19 08:30AM	BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors GlobeNewswire
Nov-22-19 09:48AM	The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical Zacks
Nov-20-19 10:00AM	What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Nov-19-19 09:26AM	Protalix Finalizes Accelerated Approval Pathway for PRX-102 Zacks
Nov-14-19 10:20AM	BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View Zacks
Nov-13-19 08:00AM	IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well Zacks
07:49AM	5 Breakout Stocks for Explosive Returns Zacks
Nov-12-19 05:25PM	BioDelivery Sciences International (BDSI) Beats Q3 Earnings and Revenue Estimates Zacks
04:01PM	BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations GlobeNewswire
Nov-07-19 08:00AM	BioDelivery Sciences to Present at the 10th Annual Jefferies Global Healthcare Conference in London GlobeNewswire
Nov-06-19 05:38AM	Introducing BioDelivery Sciences International (NASDAQ:BDSI), The Stock That Zoomed 197% In The Last Three Years Simply Wall St.
Nov-05-19 10:31AM	BioDelivery Sciences International (BDSI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Nov-04-19 11:08AM	The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus Zacks
11:01AM	Zacks.com featured highlights include: Universal Forest Products, BioDelivery Sciences International, CBIZ, Euronav and The Bancorp Zacks
Nov-01-19 12:15PM	Were Hedge Funds Right About Selling BioDelivery Sciences International, Inc. (BDSI)? Insider Monkey
08:20AM	5 Stocks With Recent Price Strength to Enhance Your Return Zacks
07:45AM	5 Top Momentum Stocks in October That Still Have Upside Left Zacks
Oct-30-19 10:00AM	Here's Why Momentum Investors Will Love BioDelivery Sciences International (BDSI) Zacks
08:00AM	BioDelivery Sciences to Report Third Quarter 2019 Financial Results and Host Conference Call on November 12, 2019 GlobeNewswire
Oct-18-19 11:07AM	Moving Average Crossover Alert: BioDelivery Sciences International Zacks
08:46AM	Will BioDelivery Sciences Continue to Surge Higher? Zacks
Oct-17-19 08:57AM	New Strong Buy Stocks for October 17th Zacks
Oct-07-19 02:50PM	From Iqvia to Cree: Execs with ties to Triangle companies inked millions in Q3 stock sales American City Business Journals
Oct-01-19 08:00AM	BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic® GlobeNewswire
Sep-17-19 04:05PM	BioDelivery Sciences Announces Participation in Upcoming Investor Conferences GlobeNewswire
Sep-07-19 09:30AM	BioDelivery (BDSI) Up 8.9% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-19 08:00AM	BioDelivery Sciences Announces Upcoming Investor Conference Presentations GlobeNewswire
Aug-28-19 07:45AM	BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management GlobeNewswire
Aug-26-19 08:16PM	$572M ruling in Oklahoma opioid lawsuit could spell trouble for Triangle pharmas American City Business Journals
Aug-16-19 01:41AM	Edited Transcript of BDSI earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-19 11:55PM	BioDelivery Sciences International, Inc. (BDSI) Q2 2019 Earnings Call Transcript Motley Fool +7.94%
10:17AM	BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2 Zacks
Aug-08-19 04:05PM	BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations GlobeNewswire +6.61%
01:03PM	How Much Are BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insiders Taking Off The Table? Simply Wall St.
Aug-01-19 10:33AM	Will BioDelivery Sciences International (BDSI) Report Negative Earnings Next Week? What You Should Know Zacks +5.12%
Jul-30-19 07:45AM	BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019 GlobeNewswire
Jul-29-19 01:47PM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Jul-25-19 10:15AM	Why a career Triangle pharma executive is bringing a Georgia spin-out to the region American City Business Journals
Jul-17-19 04:30AM	3 Small-Caps That Look Like Bargains at Current Trading Levels TheStreet.com
Jul-09-19 08:00AM	BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA® GlobeNewswire
Jul-03-19 02:19PM	Perrigo Completes Ranir Acquisition, Raises '19 Guidance Zacks
11:46AM	Top Ranked Momentum Stocks to Buy for July 3rd Zacks
10:22AM	Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
Jun-28-19 02:19PM	18 Stocks Joining The Russell Indices Benzinga +5.68%
11:32AM	Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina Zacks
Jun-27-19 09:18AM	Focus on 4 Liquid Picks on the Top Rung for Robust Returns Zacks
Jun-25-19 09:00AM	What Makes BioDelivery (BDSI) a New Strong Buy Stock Zacks
Jun-24-19 08:00AM	BioDelivery Sciences Expands Upon Report from Pain Management Task Force GlobeNewswire
Jun-21-19 10:37AM	The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International Zacks
Jun-20-19 09:18AM	5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints Zacks
08:00AM	BioDelivery Sciences Named to the Russell 3000® Index GlobeNewswire
Jun-19-19 08:43PM	Heres What Hedge Funds Think About BioDelivery Sciences International, Inc. (BDSI) Insider Monkey
Jun-05-19 09:30AM	Why Is BioDelivery (BDSI) Down 12.3% Since Last Earnings Report? Zacks
May-31-19 08:33AM	Triangle company uses new financial strength to lock down favorable loan American City Business Journals
May-29-19 04:10PM	BioDelivery Sciences Announces Upcoming Investor Conference Presentations GlobeNewswire
May-28-19 04:10PM	BioDelivery Sciences Strengthens Financial Position with Debt Refinancing GlobeNewswire
07:46AM	Can You Imagine How Chuffed BioDelivery Sciences International's (NASDAQ:BDSI) Shareholders Feel About Its 108% Share Price Gain? Simply Wall St.
May-23-19 09:19AM	The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology Zacks
May-22-19 07:21AM	5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon Zacks
May-21-19 09:00AM	All You Need to Know About BioDelivery (BDSI) Rating Upgrade to Buy Zacks
May-14-19 12:50AM	Edited Transcript of BDSI earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-07-19 09:40AM	BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat Zacks
May-06-19 10:03PM	BioDelivery Sciences International, Inc. (BDSI) Q1 2019 Earnings Call Transcript Motley Fool
06:45PM	BioDelivery Sciences International (BDSI) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:40PM	BioDelivery: 1Q Earnings Snapshot Associated Press
04:05PM	BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations GlobeNewswire
May-02-19 10:32AM	Will BioDelivery Sciences International (BDSI) Report Negative Q1 Earnings? What You Should Know Zacks

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also develops buprenorphine extended release injection, an injectable microparticle formulation of buprenorphine for the treatment of opioid dependence and chronic pain. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Plesha Scott M.	See Remarks	Mar 18	Sale	3.55	15,000	53,250	249,003	Mar 18 04:19 PM
ODONNELL FRANCIS E JR	Director	Mar 17	Sale	3.63	30,500	110,715	656,072	Mar 18 04:18 PM
Plesha Scott M.	See Remarks	Mar 16	Option Exercise	0.00	29,167	0	243,170	Mar 18 04:19 PM
ODONNELL FRANCIS E JR	Director	Mar 16	Option Exercise	0.00	77,500	0	688,754	Mar 18 04:18 PM
Vollins James	See Remarks	Mar 16	Sale	3.50	3,833	13,416	0	Mar 18 04:20 PM
ODONNELL FRANCIS E JR	Director	Mar 16	Sale	3.60	38,750	139,500	686,572	Mar 18 04:18 PM
ODONNELL FRANCIS E JR	Director	Feb 03	Sale	5.31	8,000	42,480	548,754	Feb 04 07:21 PM
Cukier Herm	Chief Executive Officer	Feb 03	Sale	5.16	31,850	164,346	35,781	Feb 04 07:25 PM
Smith Thomas B	Chief Medical Officer	Jan 31	Option Exercise	0.00	7,666	0	7,666	Feb 04 07:31 PM
Plesha Scott M.	See Remarks	Jan 31	Option Exercise	0.00	13,333	0	205,669	Feb 04 07:29 PM
Cukier Herm	Chief Executive Officer	Jan 31	Option Exercise	0.00	31,250	0	67,631	Feb 04 07:25 PM
Vollins James	See Remarks	Jan 31	Option Exercise	0.00	3,833	0	3,833	Feb 04 07:19 PM
Smith Thomas B	Chief Medical Officer	Jan 31	Sale	5.38	2,927	15,747	4,739	Feb 04 07:31 PM
Plesha Scott M.	See Remarks	Jan 21	Sale	5.77	15,000	86,550	192,336	Jan 23 04:28 PM
Coelho Mary Theresa	See Remarks	Jan 16	Sale	5.98	42,018	251,268	12,018	Jan 17 04:06 PM
Coelho Mary Theresa	See Remarks	Jan 15	Option Exercise	2.46	54,036	133,172	54,036	Jan 17 04:06 PM
Sirgo Mark A	Director	Jan 07	Sale	5.65	13,353	75,444	1,478,124	Jan 09 04:03 PM
Sirgo Mark A	Director	Jan 06	Sale	5.84	18,600	108,624	1,491,477	Jan 06 08:48 PM
Sirgo Mark A	Director	Jan 03	Sale	6.00	13,857	83,142	1,510,077	Jan 06 08:48 PM
Sirgo Mark A	Director	Jan 02	Sale	6.09	54,190	330,017	1,523,934	Jan 06 08:48 PM
ODONNELL FRANCIS E JR	Director	Jan 02	Sale	6.10	8,000	48,800	556,754	Jan 03 04:23 PM
ODONNELL FRANCIS E JR	Director	Dec 26	Sale	7.00	10,000	70,000	554,754	Dec 30 05:40 PM
Broadfin Healthcare Master Fun	Director	Dec 20	Sale	6.32	1,000,000	6,320,000	2,300,066	Dec 20 07:51 PM
Broadfin Healthcare Master Fun	Director	Dec 18	Sale	6.49	1,000,000	6,485,000	3,300,066	Dec 20 07:51 PM
Plesha Scott M.	See Remarks	Dec 11	Sale	6.36	50,000	318,000	207,336	Dec 13 04:07 PM
Cukier Herm	Chief Executive Officer	Dec 02	Option Exercise	2.18	38,461	83,845	74,842	Dec 04 04:17 PM
Cukier Herm	Chief Executive Officer	Dec 02	Sale	6.82	38,461	262,304	36,381	Dec 04 04:17 PM
ODONNELL FRANCIS E JR	Director	Dec 02	Sale	6.86	8,000	54,880	564,754	Dec 04 04:13 PM
Broadfin Healthcare Master Fun	Director	Nov 18	Sale	5.90	1,793,757	10,584,165	300,066	Nov 19 09:31 PM
Plesha Scott M.	See Remarks	Nov 18	Sale	6.06	25,000	151,500	257,336	Nov 19 04:36 PM
Vollins James	See Remarks	Nov 15	Option Exercise	3.46	29,825	103,195	29,825	Nov 19 04:39 PM
Broadfin Healthcare Master Fun	Director	Nov 15	Sale	6.04	2,206,243	13,319,089	2,093,823	Nov 19 09:31 PM
Vollins James	See Remarks	Nov 15	Sale	6.09	29,825	181,634	0	Nov 19 04:39 PM
Davis Todd C	Director	Nov 15	Sale	6.11	200,000	1,222,000	237,914	Nov 19 04:38 PM
ODONNELL FRANCIS E JR	Director	Nov 01	Sale	5.83	8,000	46,640	572,754	Nov 05 04:31 PM
ODONNELL FRANCIS E JR	Director	Oct 28	Option Exercise	3.47	32,500	112,775	613,254	Oct 30 04:33 PM
ODONNELL FRANCIS E JR	Director	Oct 28	Sale	6.00	32,500	195,000	580,754	Oct 30 04:33 PM
Sirgo Mark A	Director	Oct 18	Sale	5.15	84,228	433,774	1,578,124	Oct 22 04:36 PM
Sirgo Mark A	Director	Oct 17	Sale	5.15	31,860	164,079	1,662,352	Oct 17 05:32 PM
Sirgo Mark A	Director	Oct 16	Sale	5.15	8,912	45,897	1,694,212	Oct 17 05:32 PM
ODONNELL FRANCIS E JR	Director	Oct 15	Option Exercise	2.26	32,500	73,450	613,254	Oct 17 05:26 PM
Sirgo Mark A	Director	Oct 15	Sale	4.98	103,321	514,539	1,703,124	Oct 17 05:32 PM
ODONNELL FRANCIS E JR	Director	Oct 15	Sale	5.00	32,500	162,500	580,754	Oct 17 05:26 PM
ODONNELL FRANCIS E JR	Director	Oct 01	Sale	4.34	8,000	34,720	580,754	Oct 03 04:11 PM
Sirgo Mark A	Director	Sep 19	Sale	4.79	24,506	117,384	1,806,445	Sep 19 05:02 PM
Sirgo Mark A	Director	Sep 18	Sale	4.77	43,686	208,382	1,830,951	Sep 19 05:02 PM
Sirgo Mark A	Director	Sep 17	Sale	4.79	157,177	752,878	1,874,637	Sep 19 05:02 PM
ODONNELL FRANCIS E JR	Director	Sep 03	Sale	4.29	8,000	34,320	588,754	Sep 04 04:08 PM
Watson W. Mark	Director	Aug 13	Option Exercise	0.00	24,739	0	35,979	Aug 15 04:29 PM
Davis Todd C	Director	Aug 13	Option Exercise	0.00	18,123	0	437,914	Aug 15 04:27 PM
KOTLER KEVIN	Director	Aug 13	Option Exercise	0.00	18,123	0	4,300,066	Aug 15 04:28 PM
Greenleaf Peter	Director	Aug 13	Option Exercise	0.00	21,144	0	24,788	Aug 15 04:25 PM
ODONNELL FRANCIS E JR	Director	Aug 01	Sale	3.82	8,000	30,560	596,754	Aug 02 04:06 PM
ODONNELL FRANCIS E JR	Director	Jul 01	Sale	4.68	8,000	37,440	604,754	Jul 03 06:00 PM
Sirgo Mark A	Director	Jun 25	Sale	4.39	90,706	398,199	2,031,714	Jun 27 06:00 PM
Sirgo Mark A	Director	Jun 12	Sale	4.21	177,495	747,254	2,122,420	Jun 13 06:00 PM
Sirgo Mark A	Director	Jun 11	Option Exercise	3.68	84,717	311,817	2,607,172	Jun 13 06:00 PM
Sirgo Mark A	Director	Jun 11	Sale	4.22	307,257	1,296,625	2,299,915	Jun 13 06:00 PM
ODONNELL FRANCIS E JR	Director	Jun 03	Sale	4.32	8,000	34,560	612,754	Jun 05 06:00 PM
Broadfin Healthcare Master Fun	Director	May 10	Sale	5.00	1,800,000	9,000,000	4,281,943	May 14 04:58 PM
Cukier Herm	Chief Executive Officer	May 09	Sale	4.92	860	4,231	36,381	May 10 06:00 PM
Cukier Herm	Chief Executive Officer	May 08	Sale	5.07	29,425	149,185	37,421	May 10 06:00 PM
ODONNELL FRANCIS E JR	Director	May 01	Sale	4.77	8,000	38,160	598,254	May 03 06:00 PM
Broadfin Healthcare Master Fun	Director	Apr 11	Sale	5.00	2,000,000	10,000,000	4,281,943	Apr 15 04:14 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience